GENINUSGENINUSGENINUS

GENINUS

No trades
See on Supercharts
Market capitalization
‪55.31 B‬KRW
‪−9.68 B‬KRW
‪6.97 B‬KRW
‪15.80 M‬
Beta (1Y)
0.61

About GENINUS

CEO
Woong-Yang Park
Headquarters
Seoul
Employees (FY)
95
Founded
2018
FIGI
BBG012PLRTX1
GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company was founded on April 20, 2018 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 389030 is 1667 KRW — it has increased by 0.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENINUS stocks are traded under the ticker 389030.
389030 stock is 4.26% volatile and has beta coefficient of 0.61. Check out the list of the most volatile stocks — is GENINUS there?
Yes, you can track GENINUS financials in yearly and quarterly reports right on TradingView.
389030 stock has fallen by 4.47% compared to the previous week, the month change is a 16.36% fall, over the last year GENINUS has showed a 26.08% decrease.
389030 net income for the last quarter is ‪−3.35 B‬ KRW, while the quarter before that showed ‪−2.58 B‬ KRW of net income which accounts for −29.88% change. Track more GENINUS financial stats to get the full picture.
Today GENINUS has the market capitalization of ‪55.56 B‬, it has decreased by 0.57% over the last week.
No, 389030 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 389030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENINUS stock right from TradingView charts — choose your broker and connect to your account.
389030 reached its all-time high on Nov 8, 2021 with the price of 6483 KRW, and its all-time low was 1620 KRW and was reached on Apr 26, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 95.00 employees. See our rating of the largest employees — is GENINUS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENINUS technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENINUS stock shows the sell signal. See more of GENINUS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENINUS EBITDA is ‪−7.97 B‬ KRW, and current EBITDA margin is −114.37%. See more stats in GENINUS financial statements.